Study Objectives: To measure sleeping difficulty and sleep quality among older women, explore experience and attitudes towards sleep, and test for negative association between difficulty sleeping and health-related quality of life. Design: Four-year longitudinal study. Setting: Women were participants in the Australian Longitudinal Study on Women's Health. Participants: Women were sampled according to use of sleeping medication and classified into 4 groups: sleeping badly and using sleeping medications; not sleeping badly, but using sleeping medications; sleeping badly, not using sleeping medications; not sleeping badly, not using sleeping medications. Interventions: None. Measurements and Results: Sleeping difficulty and sleeping-medication use were measured at Survey 1, Survey 2 (3 years later), and Survey 3 (4 years later). Survey 3 included: Nottingham Health Profile Sleep Subscale, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, Geriatric Depression Scale, Duke Social Support Index, Medical Outcomes Study Short-Form 36-item Health Survey, and a 21-item life events scale. Survey 3 was returned by 1011 women (84%). Sleeping problems were negatively associated with SF-36 subscale scores. Most associations remained significant after comorbid conditions, Geriatric Depression Scale, life events scores, and medication use were added to models. Most women with sleeping problems (72%) sought help from a doctor, and 54% used prescribed sleeping medications in the past month. Conclusions: Sleeping difficulty is a serious symptom for older women and is associated with poorer quality of life. Some of this effect can be explained by comorbidities, depression scores, life events, and use of sleeping medications. 
INTRODUCTION

SLEEPING DIFFICULTY IS A COMMON COMPLAINT AMONG OLDER WOMEN
AND IS ASSOCIATED WITH PHYSICAL AND MENTAL PROBLEMS. 6 IN AUSTRALIA, sleeping difficulty has been reported by 18% of women aged 75 years and over and 12% of women aged 65 to 74 years. 1 Morgan and Clarke 6 report that insomnia is experienced by 1 in 3 individuals aged 65 and over in England. Population studies in other countries also report a high prevalence of sleeping difficulty and an increasing prevalence among women as their age increases. [3] [4] [5] 7, 8 While the prevalence of insomnia among older women is not new or controversial, there is controversy as to whether sleeping problems are a benign issue for older women or whether they are the result of age-related decline in physical health. For example, it has been suggested that sleep disturbance is normal for older people, due to age-related physiologic changes in circadian rhythms and sleep architecture. 9, 10 However, this assumption is not supported by the small amount of population data that are available. Although sleep disturbances increase with aging, changes in sleep pattern do not necessarily lead to symptoms of sleep disturbance and complaints of insomnia. 11 Further, some research indicates that poor sleep among older adults may be a prodromal symptom for underlying physical and or psychiatric illness, 12 as well as a possible precursor of these conditions. 13, 14 Despite the reported prevalence of sleeping difficulty, very little is known about how this symptom is experienced or responded to by women in the community or about the short-or long-term impact on affected women's quality of life. This study was undertaken to explore women's experience of sleeping difficulty and the relationship between this symptom and quality of life. The study builds on earlier work that described the prevalence and correlates of sleeping difficulty in a cross-sectional analysis of data from 12,624 community-dwelling women aged 70 to 75 years who were participants in the 1996 baseline survey (Survey 1) of the Australian Longitudinal Study on Women's Health (ALSWH). 2, 15 Of the 12,624 participants in Survey 1 ALSWH, 17% reported they "often" experience "difficulty sleeping," and approximately 18% (n=2287) of women reported use of sleeping medication within the previous 4 weeks. Further, there were strong statistical associations between self-reported sleeping difficulty and healthrelated quality of life. 2 The first follow-up of these women (Survey 2) occurred in 1999, 3 years after collection of baseline data, and obtained responses from 10,430 of the original cohort. Analysis of these longitudinal data demonstrated a relationship between reported sleeping difficulty at Survey 1 and reduced quality of life at Survey 2, even after adjustment for comorbid conditions and symptoms and concurrent use of sleeping medications. 15 This study collects further data from randomly selected subsamples of women who participated in Survey 2 of ALSWH. Specifically, the aims were (1) to gain more detailed measures of women's sleeping difficulty and sleep quality using psychometrically valid measures, (2) to explore the experience and attitudes toward sleep among women who have difficulty sleeping and/or who use sleeping medication, and (3) to test the hypothesis that difficulty sleeping is adversely associated with changes in healthrelated quality of life.
METHOD
Sampling and Data Collection
Women in this study are participants in ALSWH, which is designed to track the health of women over a period of up to 20 years, and were aged 70 to 75 years at the commencement of the study in 1996. The study sample was drawn from the database of the Health Insurance Commission, the universal provider of basic health insurance, which involves all women in Australia (including nonresidents). All women had completed omnibus-style health surveys in 1996 (Survey 1) and in 1999 (Survey 2). The surveys collected demographic and health data using a wide range of questionnaire items measuring physical, social, and mental health (including symptoms of sleeping difficulty) and healthcare use ( including use of sleeping medications).
A specific survey on sleep was distributed to a subsample of women (Survey 3 of this study). Women were randomly selected for this survey from 4 mutually exclusive groups: (1) those who had sleeping difficulty and used sleeping medications, (2) those who had sleeping difficulty but did not use sleeping medications, (3) those who did not have sleeping difficulty but used sleeping medications, (4) those who did not have sleeping difficulty and did not use sleeping medications. These groups were constructed by cross-tabulating responses to Survey 2 items "Have you taken any medication during the PAST 4 WEEKS to help you sleep (yes/no)" and "Do you have problems …sleeping badly at night (yes/no)." The subsample was selected such that there were 605 women who used sleeping medications and 605 women who did not use sleeping medications. The sampling also ensured that prevalence of medication use among the women who reported sleeping difficulty was maintained.
The Women were asked to complete the survey and return it in the reply-paid envelope provided. One reminder card was sent after 1 week. and women who had not returned their surveys within 3 weeks were telephoned to encourage their participation.
Measures
The NHP sleep subscale was included in Survey 2 and Survey 3. The subscale consists of 1 item on sleeping-medication use and 4 items measuring sleep: "waking in the early hours of the morning," "lie awake most of the night," "takes a long time to get to sleep", "sleep badly at night." 16 The items are weighted and added together to yield a subscale score from 0 ("no problem") to 100 ("Yes" to all items). 17 The PSQI is a valid reliable measure of sleep quality that can be used to discriminate between good and poor sleepers. The PSQI produces 7 component scores (Sleep Quality, Sleep Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disturbance, Sleeping Medications, Daytime Dysfunction) and 1 global score and has an overall reliability coefficient (α) of .83 and a test-retest reliability (Pearson) of 0.85. 18 The PSQI was used in Survey 3 only.
The ESS consists of 8 questions and yields a score of 0 to 24. This is a simple self-administered questionnaire that is one of the most widely used subjective tests for sleepiness (Survey 3 only). 19 The Medical Outcomes Study Short-Form 36-item Health Survey (SF-36) is a widely used tool designed to measure health-related quality of life. 20 The instrument provides an 8-scale health profile and 2 component summary scores representing physical and mental health. The scales measure (1) physical functioning; (2) bodily pain; (3) role limitations due to physical health problems; (4) general health perceptions; (5) vitality, energy, or fatigue; (6) general mental health, covering psychological distress or well-being; (7) role limitations due to emotional problems; and (8) social functioning. Higher scores on each scale represent better quality of life (eg, a high score on the "Physical Functioning" subscale indicates good physical health-related quality of life; a low score on the "Bodily Pain" subscale indicates poorer quality of life due to the presence of pain).
Items to assess sleep attitudes and related behaviors were also included in Survey 3. These items were developed following indepth qualitative interviews with a separate random sample of 11 women who had reported "sleeping badly" at Survey 2. This "insider's view" of sleeping difficulty was used to develop statements describing reasons for not sleeping, attitudes to sleep (with a 5-point Likert scale for responses), help-seeking behaviors, and lists of behaviors that women engage in when they cannot sleep.
Measures of other factors potentially associated with sleep disturbance were collected at Survey 1 and Survey 2. These factors included use of sleeping medications, medical conditions and symptoms, depression, and life events. Medical conditions included arthritis, diabetes, heart disease, hypertension, stroke, thrombosis, low iron, asthma, bronchitis/emphysema, osteoporosis, breast cancer, bowel cancer, other cancer, depression, anxiety, and Alzheimer disease or dementia. Depression was measured using the Geriatric Depression Scale (GDS), 21 and life events were measured using a 21-item life-events scale. Women were also asked to write down the name of sleeping medications used in the previous month. Basic demographic data were collected at Survey 1, a and marital status was measured at Survey 1 and Survey 2. Information on smoking status, body mass index, and physical activity was also collected at Survey 1 and Survey 2.
Statistical Analysis
Coding of Responses and Construction of Scores
NHP, ESS, and PSQI scores and subscale scores were calculated according to published methods, [17] [18] [19] and the median, mean and standard deviation of each score was calculated for each group. Responses to items measuring sleeping difficulty at Survey 1, Survey 2, and Survey 3 were used to classify women into 4 transition categories relating to stability or change in reported sleeping difficulty: no problem at any time, sleep problem in the past (Survey 1 and/or Survey 2 but not Survey 3), longstanding sleep problem (Survey 3 and Survey 2 and/or Survey 1), and new problem (Survey 3 only).
Responses to items measuring symptoms that women reported as causing trouble sleeping were classified as "less than once a week" or "once or more times a week." Items describing attitudes towards sleep were categorized as disagree/strongly disagree, neutral, or agree/strongly agree. Responses to items about behaviors women engage in when they cannot sleep were dichotomous ("yes" or "no"). Names of sleeping medications used in the last month were coded and classified.
Descriptive Analyses
Data on sleeping difficulty, medication use, symptoms that may interfere with sleep, attitudes to sleep, and behaviors to aid sleep were reported separately for each of the 4 groups. Welch's variance-weighted 1-way analysis of variance (which is robust to the assumption of equal within-group variances) was used to explore the relationships between group and mean scores for sleep indexes (NHP, ESS and PSQI). A χ 2 test was used to assess the relationships between the proportions of women who reported "difficulty sleeping," "use of sleeping medications," items of NHP, and the 4 sampling groups. Posthoc pairwise analyses were performed to identify which groups were significantly different from one another.
Analysis of Association Between Sleeping Difficulty and Change in Health-Related Quality of Life
Sets of nested multiple linear regression models were constructed. In each set of models, the explanatory variable was 1 of the 4 measures of sleeping difficulty (scores for NHP sleep subscale, PSQI, and ESS from Survey 3 or transition categories), and the outcome factors were the SF-36 subscale and component summary scores from Survey 1 to Survey 3. The nested models in each set are listed below.
Model 1
Sleeping difficulty and change in SF-36 subscale and component summary scores, with Survey 1 SF-36 component summary scores, area of residence, cigarette smoking status, body mass index, exercise status, and age were treated as covariates. These covariates were included in this basic model because other analyses involving data from participants in the ALSWH indicate that these factors are strongly associated with quality of life, as measured by the SF-36. 22 
Model 2
The number of comorbid conditions, number of symptoms, GDS, and number of life events were added to model 1 as covariates.
Model 3
The frequency of use of sleeping medications in the past month was added to model 2. All analyses were conducted using SAS Version 8 (SAS Institute, Inc., Cary, NC).
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RESULTS
A total of 1011 women returned Survey 3 (84% return rate).
The basic demographic characteristics of the women providing data for this study are described in Table 1 . However, due to the sampling strategy, it was not expected that women in this study would be representative of the population of women of this age, nor of the parent sample. Data on sleep quality for each of the 4 groups are described in Table 2 .
Sleeping Difficulty and Sleep Quality for Women Participating in the Study
There were significant differences between groups in terms of mean scores on NHP sleep subscale, PSQI, and ESS (See Table  2 ). Using self-reported sleeping difficulty at Survey 1 and report of any of the 4 sleep disturbance items of NHP (excluding medication use) at Survey 2 and Survey 3 as comparable indexes, women were classified into 4 transition categories: (1) no sleep problems at any time (107 women, 11%); (2) problem in the past (Survey 1 and/or Survey 2 but not Survey 3) (142 women, 14%); (3) longstanding problems (Survey 3 and Survey 1 and/or Survey 2) (665 women, 66%); and (4) newly reported sleeping difficulty (Survey 3 only) (60 women, 21%). Data were missing for 37 women.
Among women in the selected stratified samples included in this study with any sleeping problems on NHP on Survey 3, the average self-reported duration of problems was approximately 10 years (mean=13.6, median 10, interquartile range 4-20), indicating that the sleeping difficulties experienced by women in the study were often longstanding.
A majority of women selected because of their use of sleeping medications at Survey 2 (Groups 1 and 2) were still using medications at Survey 3 (76% and 78%), and some women who had not reported medication use at Survey 2 (Groups 3 and 4) reported use at Survey 3 (35% and 14%). Classification of the medications used by women in the study during the previous month inInsomnia Among Older Women-Byles et al 974 dicated that 87% of the women in the study who reported using medications were using hypnotic sedatives (eg, temazepam 42%, nitrazepam 12%, oxazepam 21%), with the remainder using overthe-counter medications (8%), herbal remedies (10%), or both. Among women in Groups 1 and 3 who had sleeping difficulty at Survey 2, 30% and 33%, respectively, said that their sleeping problems commenced when they were widowed, and 24% in each group said their problems started during a period of illness. Approximately 8% of women said their problems started after moving house, and roughly 5% said their problems started after an accident. Approximately 10% said their sleeping problems started after some other event, and around 30% could not attribute their problems to a cause.
Symptoms That Interfere With Sleep, Attitudes Toward Sleeping Difficulty, and Help-Seeking Behaviors
Women with sleeping difficulty (Groups 1 and 3 ) reported a range of other symptoms (see Table 3 ), most notably pain, breathing discomfort or coughing/snoring, and bad dreams that they associated with difficulty sleeping. Having to get up to use the bathroom was reported by a large proportion of women in these groups.
Women's attitudes toward sleep are presented in Table 4 . Most women with sleeping difficulty or medication use (Groups 1, 2, and 3) agreed that it is harder to sleep when you get older, and, while 76% of those in Group 4 agreed they get all the sleep they need, only 35% to 52% of women in the other Groups agreed with this statement. Approximately 20% to 30% of the women in Groups 1, 2, and 3 said they are "too worried" to sleep, and 10% of women who sleep badly and use medications said they are "afraid to sleep."
Women had tried a variety of strategies to help them sleep (See Table 5 ), with the most common being reading and listening to the radio. A minority of women used alcohol to help sleep. Some women used coffee or tea to help them sleep, which is against sleep hygiene advice. Welch's analysis of variance data reported separately for each of the 4 samples so as to not distort the estimated means and proportions through oversampling. After adjustment for multiple comparisons using Bonferroni corrections, significant differences in means/proportions (P<.05) between each group obtained from pairwise comparisons are denoted in square brackets. For example, the proportion of those reporting self-reported difficulty in sleeping in group 1 differs significantly from groups 2 and 3.
Association Between Sleeping Difficulty and Health-Related Quality of Life
Multiple regression modeling was undertaken as a stepwise procedure resulting in sets of nested models. In each set, the outcome variable was 1 of the 8 subscales or 1 of the 2 component summary scales of the SF-36, and the explanatory variable was 1 of the measures of sleeping difficulty (Survey 3 NHP sleep subscale, PSQI, ESS, or sleep-transition categories). However, since all sets of models yielded similar results, only the results for PSQI are reported (Table 6 ). In the simplest model, PSQI was negatively associated with Survey 3 SF-36 subscale scores after adjustment for Survey 1 SF-36 Physical Components Summary Score and Mental Health Components Summary Score, indicating that higher scores for sleeping difficulty are associated with lower quality of life. Except for the Physical Functioning and Social Functioning subscales and the Physical Components Summary Score, these associations remained significant after comorbid conditions, GDS, and life-events scores were added to the models and, in the final model, after adding the frequency of use of medications in the past month. The association between sleeping difficulty and Social Functioning was not significant once the model was adjusted for the number of diagnosed medical and mental health conditions, the GDS, and the number of life events reported at Survey 2 (Model 2). The association between sleeping difficulty and Physical Functioning was significant in Model 2 but was not significant in Model 3 after the addition of sleepingmedication use.
DISCUSSION
The ALSWH provided a prime opportunity to explore women's experience of sleeping difficulty and the relationship between sleep disturbance and quality of life. Participants in ALS-WH are broadly representative of the Australian population, with overrepresentation of women in urban, rural, and remote areas. The use of stratified sampling for Survey 3 enabled statistically efficient collection of data on 4 separate selected groups of womInsomnia Among Older Women-Byles et al 976 *P value from a χ 2 test to test the hypotheses that percentages were equal across the 4 groups. Data reported separately for each of the 4 samples so as to not distort the estimated means and proportions through oversampling. After adjustment for multiple comparisons using Bonferroni corrections, significant differences in proportions (P<.05) between each group obtained from pairwise comparisons are denoted in square brackets. Data reported separately for each of the 4 samples so as to not distort the estimated means and proportions through oversampling. After adjustment for multiple comparisons using Bonferroni corrections, significant differences in proportions (P<.05) between each group obtained from pairwise comparisons are denoted in square brackets.
en who varied according to whether they had reported difficulty sleeping and whether they used medications to assist sleep. These data allow comparisons of women across groups; however, they do not provide an overall prevalence of behaviors for women in the community in general, due to the oversampling of women with problems and those who use sleeping medications. Another limitation is that there is a potential for misclassification of women according to sleeping-medication use if women were temporarily not taking medications at Survey 2. To avoid this potential for misclassification, the final regression models were adjusted for medication use at Survey 3 so that the impact of current medications could be taken into account.
Similarly, there is a potential for misclassification of women with sleeping difficulty. To avoid this problem, a variety of measures of sleep quality and sleep disturbance (such as the PSQI and ESS) were used. The variety of measurements allowed robust assessment of the relationship between sleep and the 4-year longitudinal change in health-related quality of life, as measured by the SF-36 Health Survey. In this paper, we have chosen to report models of the association between sleeping difficulty at Survey 3, as measured by PSQI, and change in quality of life because the PSQI was the most detailed measure of sleep obtained. However, models incorporating other measures of the predictor variable, including those that used sleep data from earlier surveys, produced similar results.
Regardless of the method and the timing of measurement of sleeping difficulty, a consistent result emerged: sleep disturbance was associated with a greater negative change in SF-36 scores (indicating a greater reduction in health-related quality of life). For some domains (role limitations due to physical health problems, bodily pain, general health perceptions, vitality, role limitations due to emotional problems, and general mental health), a statistically significant relationship remained after the effects of associated comorbidities, depression scores, life events, and use of sleeping medications had been adjusted for in the models. While no causal relationship can be inferred, the finding Data reported separately for each of the 4 samples so as to not distort the estimated proportions through oversampling. that sleep disturbance is associated with declining health-related quality of life is of importance. This finding is not consistent with the widespread acceptance that sleep disturbance is normal for older people, due to age related physiologic changes in cardiac rhythms and sleep architecture, and has no pathologic significance. 9, 10 It has been suggested that the mechanism for sleep disturbance among older people may be triggered by social and physical situations against a background of physiologic change. 24 In this study, many women with difficulty sleeping attributed their sleeping problems to some event in their lives or to illness, and women commonly reported that they could not sleep because of pain or breathing difficulty. In other studies, symptoms such as pain and dyspnea have been found to interfere with sleep onset and sleep maintenance, and medications such as diuretics and bronchodilators have been shown to trigger insomnia. 9 Medications can also cause bad dreams, a relatively frequent complaint among the women who reported sleeping difficulty in this study.
In the nested models, it was evident that some of the poor health-related quality of life associated with sleeping difficulty can be explained by underlying medical conditions, depression, life events, and use of sleeping medications. This effect was particularly true for the association between sleeping difficulty and social function, and between sleeping difficulty and physical functioning (and the Physical Components Score of the SF-36), and suggests that these underlying factors may be associated with both sleeping difficulty and these quality of life domains. However, for the other domains of SF-36, a statistically significant association remained after the addition of these factors to the model, suggesting that sleeping difficulty may have an effect on these health aspects that is beyond the effect of underlying medical conditions, depression, life events, and sleeping medications.
Sleeping difficulty is common among women in the population1-5 and can have direct or indirect impact on quality of life. Serious consideration of appropriate actions that women can take to assist their sleep is therefore warranted. In this study, a majority of women with sleeping problems had sought help from some source, most often their doctor, and the use of medications was a common response by many women and their doctors.
Overall, there was a trend toward increasing use of sleeping medications over the study period. Even among women classified as not using medications at Survey 2, some women had used sleeping medications at Survey 1, and a greater proportion reported using medications at Survey 3. The consumption of sedatives and hypnotics among women in this age group has been an issue of concern due to the risks of adverse consequences such as drowsiness, confusion, ataxia, dizziness, impaired motor coordination, and increased risk of falls. [25] [26] [27] [28] [29] However, newer medications with shorter half-lives may have fewer negative outcomes. Other sleep-aiding strategies commonly tried by women included drinking hot milk and herbal teas. Some women were using drinks such as tea and coffee that contain caffeine to assist their sleep, so these women may benefit from better advice on how to enhance sleep. Also, given the high proportions of women in the groups with sleeping difficulty who listen to the radio, this medium could be explored as a way to deliver health-promotion messages about sleep enhancement.
CONCLUSION
While many older women believe that less sleep is normal with increasing age, they also believe that lack of sleep is a problem. This attitude is reflected in a high probability of seeking help and medication use among those with sleeping difficulty. Moreover, longitudinal data analysis indicated a negative association between sleeping difficulty and change in quality of life. These results underscore the importance of strategies to assist women to find safe methods to deal with sleeping difficulty and to recognize sleeping difficulty as a valid symptom, not just a normal part of aging.
